Skip to main content

ACS & ASCO are Stronger Together: Cancer.Net content is now available on

Chemotherapy for Soft Tissue Sarcomas

Chemotherapy (chemo) is the use of drugs given into a vein or taken by mouth to treat cancer. These drugs enter the bloodstream and reach all areas of the body, making this treatment useful for cancer that has spread (metastasized) to other organs. Depending on the type and stage of sarcoma, chemotherapy may be given as the main treatment or as an adjuvant (addition) to surgery. Different types of sarcoma respond better to chemo than others and also respond to different types of chemo. Chemotherapy for soft tissue sarcoma generally uses a combination of several anti-cancer drugs.

Chemo drugs used for sarcoma

The most commonly used drugs are ifosfamide (Ifex®) and doxorubicin (Adriamycin®). When ifosfamide is used, the drug mesna is also given. Mesna is not a chemo drug. It's used to protect the bladder from the toxic effects of ifosfamide.

Other chemo drugs may be used as well, including dacarbazine (DTIC), epirubicin, temozolomide (Temodar®), docetaxel (Taxotere®), gemcitabine (Gemzar®), vinorelbine (Navelbine®), trabectedin (Yondelis®), and eribulin (Halaven®).

When several drugs are used together, the combination is given a shortened name such as: MAID (mesna, Adriamycin [doxorubicin], ifosfamide, and dacarbazine) or AIM (Adriamycin [doxorubicin], ifosfamide, and mesna).

Isolated limb perfusion (ILP)

ILP is a different way to give chemo. The circulation of the limb (arm or leg) with the tumor in it is separated from that of the rest of the body. Chemo is then given just to that limb. Sometimes the blood is warmed up a bit to help the chemo work better (this is called hyperthermia). ILP may be used to treat tumors that cannot be removed or to treat high-grade tumors before surgery. It can help shrink tumors, but it isn’t clear that it helps patients live longer than standard chemo. ILP should only be done at centers with a lot of experience in giving chemo this way.

Chemo side effects

Chemotherapy drugs kill cancer cells but also damage some normal cells. This causes side effects. Side effects depend on the type of drugs, the amount taken, and the length of treatment. Common chemo side effects include:

  • Nausea and vomiting
  • Loss of appetite
  • Loss of hair
  • Mouth sores
  • Fatigue
  • Low blood counts

Because chemotherapy can damage the blood-producing cells of the bone marrow, patients may have low blood cell counts. This can result in:

  • Increased chance of infection (from too few white blood cells)
  • Problems with bleeding or bruising (from too few blood platelets)
  • Fatigue and weakness (from too few red blood cells)

Most side effects go away over time once treatment is stopped. For instance, hair will grow back after treatment ends, but it might look different. There are treatments for many of the short-term side effects of chemo. For instance, drugs can be given that prevent or reduce nausea and vomiting.

Some chemo side effects can last a long time or even be permanent. For instance, doxorubicin can weaken the heart if too much is given. If you're going to get this drug, your doctor might check your heart function with special studies before starting this drug. The doctor will also watch your heart function during therapy.

Some chemo drugs cause nerve damage (called neuropathy), leading to numbness, tingling, or even pain in the hands and feet. For more on this, see Peripheral Neuropathy Caused by Chemotherapy.

Chemotherapy may also permanently damage ovaries or testicles, causing infertility (not being able to have children). This is covered in more detail in Fertility and Women With Cancer and Fertility and Men With Cancer.

More information about chemotherapy

For more general information about how chemotherapy is used to treat cancer, see Chemotherapy.

To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.

The American Cancer Society medical and editorial content team

Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.

Last Revised: April 6, 2018

American Society of Clinical Oncology. Sarcoma, Soft Tissue: Treatment Options. 08/2017. Accessed at on April 2, 2018.

Helman LJ, Maki RG. Sarcomas of soft tissue. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE. Abeloff‘s Clinical Oncology. 5th ed. Philadelphia, PA. Elsevier: 2014: 1753-1791.

MacNeill AJ, Gupta A, Swallow CJ. Randomized Controlled Trials in Soft Tissue Sarcoma: We Are Getting There! Surg Oncol Clin Am. 2017;26:531-544.

National Cancer Institute. Adult Soft Tissue Sarcoma Treatment (PDQ®)–Patient Version. May 15, 2017. Accessed at on April 2, 2018.

National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Soft Tissue Sarcoma, Version 1.2018 -- October 31, 2017. Accessed at on April 2, 2018.

Singer S, Maki R, O’Sullivan B. Soft tissue sarcoma In: DeVita VT, Heilman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011:1533-1577.

Villalobos VM, Byfield SD, Ghate SR, Adejoro O. A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the US. Clin Sarcoma Res. 2017 Nov 9;7:18.  

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.